Literature DB >> 20053797

Isoflurane via TGF-beta1 release increases caveolae formation and organizes sphingosine kinase signaling in renal proximal tubules.

Joseph H Song1, Mihwa Kim, Sang Won Park, Sean W C Chen, Stuart M Pitson, H Thomas Lee.   

Abstract

We previously showed that the inhalational anesthetic isoflurane protects against renal proximal tubule necrosis via isoflurane-mediated stimulation and translocation of sphingosine kinase-1 (SK1) with subsequent synthesis of sphingosine-1-phosphate (S1P) in renal proximal tubule cells (Kim M, Kim M, Kim N, D'Agati VD, Emala CW Sr, Lee HT. Am J Physiol Renal Physiol 293: F1827-F1835, 2007). We also demonstrated that the anti-necrotic and anti-inflammatory effect of isoflurane is due in part to phosphatidylserine (PS) externalization and subsequent release of transforming growth factor-beta1 (TGF-beta1) (Lee HT, Kim M, Kim J, Kim N, Emala CW. Am J Nephrol 27: 416-424, 2007). In this study, we tested the hypothesis that isoflurane, via TGF-beta1 release, increases caveolae formation in the buoyant fraction of the cell membrane of human renal proximal tubule (HK-2) cells to organize SK1 and S1P signaling. To detect SK1 protein in the caveolae/caveolin fractions, we overexpressed human SK1 in HK-2 cells (SK1-HK-2). SK1-HK-2 cells exposed to isoflurane increased caveolae/caveolin formation in the buoyant membrane fractions which contained key signaling intermediates involved in isoflurane-mediated renal tubule protection, including S1P, SK1, ERK MAPK, and TGF-beta1 receptors. Furthermore, treating SK1-HK-2 cells with recombinant TGF-beta1 or PS liposome mixture increased caveolae formation, mimicking the effects of isoflurane. Conversely, TGF-beta1-neutralizing antibody blocked the increase in caveolae formation induced by isoflurane in SK1-HK-2 cells. The increase in SK1 activity in the caveolae-enriched fractions from isoflurane-treated nonlentivirus-infected HK-2 cells, while smaller in magnitude, was qualitatively similar to that found in the SK1-HK-2 cell line. Finally, isoflurane also increased caveolae formation in the kidneys of TGF-beta1 +/+ mice but not in TGF-beta1 +/- mice (mice with reduced levels of TGF-beta1). Our study demonstrates that isoflurane organizes several key cytoprotective signaling intermediates including TGF-beta1 receptors, SK1 and ERK, within the caveolae fraction of the plasma membrane. Our findings may help to unravel the cellular signaling pathways of volatile anesthetic-mediated renal protection and lead to new therapeutic applications of inhalational anesthetics during the perioperative period.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20053797      PMCID: PMC2853319          DOI: 10.1152/ajprenal.00115.2009

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  38 in total

1.  Compartmentation of G-protein-coupled receptors and their signalling components in lipid rafts and caveolae.

Authors:  P A Insel; B P Head; H H Patel; D M Roth; R A Bundey; J S Swaney
Journal:  Biochem Soc Trans       Date:  2005-11       Impact factor: 5.407

2.  Mechanisms of cardiac protection from ischemia/reperfusion injury: a role for caveolae and caveolin-1.

Authors:  Hemal H Patel; Yasuo M Tsutsumi; Brian P Head; Ingrid R Niesman; Michelle Jennings; Yousuke Horikawa; Diane Huang; Ana L Moreno; Piyush M Patel; Paul A Insel; David M Roth
Journal:  FASEB J       Date:  2007-02-01       Impact factor: 5.191

3.  Transforming growth factor-beta receptors localize to caveolae and regulate endothelial nitric oxide synthase in normal human endothelial cells.

Authors:  Eric A Schwartz; Eve Reaven; James N Topper; Philip S Tsao
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

Review 4.  Caveolae and lipid rafts: G protein-coupled receptor signaling microdomains in cardiac myocytes.

Authors:  Paul A Insel; Brian P Head; Rennolds S Ostrom; Hemal H Patel; James S Swaney; Chih-Min Tang; David M Roth
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

5.  Role of lipid rafts in ceramide and nitric oxide signaling in the ischemic and preconditioned hearts.

Authors:  Peter Der; Jianhua Cui; Dipak K Das
Journal:  J Mol Cell Cardiol       Date:  2005-12-09       Impact factor: 5.000

6.  The mechanism of membrane targeting of human sphingosine kinase 1.

Authors:  Robert V Stahelin; Jeong H Hwang; Jin-Hahn Kim; Zee-Yong Park; Korey R Johnson; Lina M Obeid; Wonhwa Cho
Journal:  J Biol Chem       Date:  2005-10-21       Impact factor: 5.157

7.  Differential protective effects of volatile anesthetics against renal ischemia-reperfusion injury in vivo.

Authors:  H Thomas Lee; Ayuko Ota-Setlik; Yulei Fu; Samih H Nasr; Charles W Emala
Journal:  Anesthesiology       Date:  2004-12       Impact factor: 7.892

8.  Sphingosine kinase 1 (SPHK1) is induced by transforming growth factor-beta and mediates TIMP-1 up-regulation.

Authors:  Masayoshi Yamanaka; Daniel Shegogue; Heuping Pei; Shizhong Bu; Alicja Bielawska; Jacek Bielawski; Benjamin Pettus; Yusuf A Hannun; Lina Obeid; Maria Trojanowska
Journal:  J Biol Chem       Date:  2004-10-12       Impact factor: 5.157

9.  Anti-inflammatory and antinecrotic effects of the volatile anesthetic sevoflurane in kidney proximal tubule cells.

Authors:  H Thomas Lee; Mihwa Kim; Michael Jan; Charles W Emala
Journal:  Am J Physiol Renal Physiol       Date:  2006-02-14

10.  Isoflurane improves survival and protects against renal and hepatic injury in murine septic peritonitis.

Authors:  H Thomas Lee; Charles W Emala; Jin Deok Joo; Mihwa Kim
Journal:  Shock       Date:  2007-04       Impact factor: 3.454

View more
  17 in total

1.  TGFβ-Mediated induction of SphK1 as a potential determinant in human MDA-MB-231 breast cancer cell bone metastasis.

Authors:  Keith R Stayrook; Justin K Mack; Donna Cerabona; Daniel F Edwards; Hai H Bui; Maria Niewolna; Pierrick Gj Fournier; Khalid S Mohammad; David L Waning; Theresa A Guise
Journal:  Bonekey Rep       Date:  2015-07-08

2.  Sphingosine kinase 2 mediates cerebral preconditioning and protects the mouse brain against ischemic injury.

Authors:  Lai Ming Yung; Ying Wei; Tao Qin; Yumei Wang; Charles D Smith; Christian Waeber
Journal:  Stroke       Date:  2011-10-06       Impact factor: 7.914

Review 3.  Volatile anesthetics and AKI: risks, mechanisms, and a potential therapeutic window.

Authors:  Kyota Fukazawa; H Thomas Lee
Journal:  J Am Soc Nephrol       Date:  2014-02-07       Impact factor: 10.121

Review 4.  Caveolins as Regulators of Stress Adaptation.

Authors:  Jan M Schilling; Brian P Head; Hemal H Patel
Journal:  Mol Pharmacol       Date:  2018-01-22       Impact factor: 4.436

5.  Targeting Hypoxia-induced Inflammation.

Authors:  Holger K Eltzschig
Journal:  Anesthesiology       Date:  2011-02       Impact factor: 7.892

6.  The protective effect and mechanism of sevoflurane on LPS-induced acute lung injury in mice.

Authors:  Qi-Feng Tang; Zhi-Yuan Fang; Cheng-Huan Shi
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

7.  Caveolae and propofol effects on airway smooth muscle.

Authors:  K J Grim; A J Abcejo; A Barnes; V Sathish; D F Smelter; G C Ford; M A Thompson; Y S Prakash; C M Pabelick
Journal:  Br J Anaesth       Date:  2012-04-27       Impact factor: 9.166

Review 8.  Ischaemic and inflammatory injury in renal graft from brain death donation: an update review.

Authors:  Anthony Fung; Hailin Zhao; Bob Yang; Qingqian Lian; Daqing Ma
Journal:  J Anesth       Date:  2016-01-08       Impact factor: 2.078

9.  Critical role of interleukin-11 in isoflurane-mediated protection against ischemic acute kidney injury in mice.

Authors:  Ahrom Ham; Mihwa Kim; Joo Yun Kim; Kevin M Brown; James Yeh; Vivette D D'Agati; H Thomas Lee
Journal:  Anesthesiology       Date:  2013-12       Impact factor: 7.892

10.  Kidney Proximal Tubular TLR9 Exacerbates Ischemic Acute Kidney Injury.

Authors:  Sang Jun Han; Hongmei Li; Mihwa Kim; Mark J Shlomchik; H Thomas Lee
Journal:  J Immunol       Date:  2018-06-13       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.